Synthetica AD Past Earnings Performance
Past criteria checks 0/6
Synthetica AD's earnings have been declining at an average annual rate of -2263.6%, while the Medical Equipment industry saw earnings growing at 5% annually. Revenues have been growing at an average rate of 111.7% per year.
Key information
-2,263.6%
Earnings growth rate
-2,263.7%
EPS growth rate
| Medical Equipment Industry Growth | 12.3% |
| Revenue growth rate | 111.7% |
| Return on equity | -13.7% |
| Net Margin | -4.8% |
| Last Earnings Update | 31 Dec 2022 |
Revenue & Expenses BreakdownBeta
How Synthetica AD makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 22 | 34 | -2 | -1 | 0 |
| 30 Sep 22 | 17 | 0 | 0 | 0 |
| 30 Jun 22 | 16 | -1 | 0 | 0 |
| 31 Mar 22 | 16 | 0 | 0 | 0 |
| 31 Dec 21 | 16 | 0 | 0 | 0 |
| 30 Sep 21 | 13 | 0 | 0 | 0 |
| 30 Jun 21 | 12 | 1 | 0 | 0 |
| 31 Mar 21 | 12 | 1 | 0 | 0 |
| 31 Dec 20 | 12 | 1 | 0 | 0 |
| 30 Sep 20 | 13 | 1 | 1 | 0 |
| 30 Jun 20 | 11 | 0 | 2 | 0 |
| 31 Mar 20 | 12 | 1 | 2 | 0 |
| 31 Dec 19 | 16 | -3 | 2 | 0 |
| 30 Sep 19 | 22 | -6 | 20 | 0 |
| 30 Jun 19 | 39 | -2 | 19 | 0 |
| 31 Mar 19 | 48 | -3 | 18 | 0 |
| 31 Dec 18 | 50 | -1 | 18 | 0 |
| 30 Sep 18 | 55 | 2 | 1 | 0 |
| 30 Jun 18 | 49 | 0 | 1 | 0 |
| 31 Mar 18 | 50 | 0 | 1 | 0 |
| 31 Dec 17 | 50 | 2 | 1 | 0 |
| 30 Sep 17 | 142 | 9 | 1 | 0 |
| 30 Jun 17 | 49 | 5 | 1 | 0 |
| 31 Mar 17 | 95 | 6 | 1 | 0 |
| 31 Dec 16 | 145 | 7 | 1 | 0 |
| 30 Sep 16 | 260 | 10 | 1 | 0 |
| 30 Jun 16 | 355 | 11 | 1 | 0 |
| 31 Mar 16 | 261 | 5 | 1 | 0 |
| 31 Dec 15 | 261 | 5 | 1 | 0 |
| 30 Sep 15 | 131 | -1 | 1 | 0 |
| 30 Jun 15 | 167 | 1 | 1 | 0 |
| 31 Mar 15 | 245 | 6 | 1 | 0 |
| 31 Dec 14 | 220 | 5 | 0 | 0 |
| 30 Sep 14 | 167 | 0 | 0 | 0 |
| 30 Jun 14 | 156 | 0 | 0 | 0 |
| 31 Mar 14 | 152 | -2 | 0 | 0 |
| 31 Dec 13 | 153 | -2 | 0 | 0 |
| 30 Sep 13 | 149 | 2 | 1 | 0 |
| 30 Jun 13 | 140 | 2 | 1 | 0 |
Quality Earnings: SYN is currently unprofitable.
Growing Profit Margin: SYN is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: Insufficient data to determine if SYN's year-on-year earnings growth rate was positive over the past 5 years.
Accelerating Growth: Unable to compare SYN's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: SYN is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (5.2%).
Return on Equity
High ROE: SYN has a negative Return on Equity (-13.73%), as it is currently unprofitable.